litlas
Log inCreate account

Reuben S. Harris

Active 1994–2025

Also published as
Reuben S Harris
147
Papers
21,730
Citations
82
h-index
138
i10-index

Citations

Citations per year for Reuben S. Harris1988: 1 citations1994: 8 citations1995: 24 citations1996: 10 citations1997: 27 citations1998: 30 citations1999: 22 citations2000: 31 citations2001: 36 citations2002: 32 citations2003: 117 citations2004: 178 citations2005: 139 citations2006: 175 citations2007: 153 citations2008: 195 citations2009: 141 citations2010: 140 citations2011: 99 citations2012: 172 citations2013: 268 citations2014: 204 citations2015: 264 citations2016: 277 citations2017: 253 citations2018: 194 citations2019: 684 citations2020: 723 citations2021: 628 citations2022: 564 citations2023: 552 citations2024: 607 citations2025: 269 citations2026: 7 citations1989–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,731 citing papers, 35.3% of this breakdownChina: 449 citing papers, 9.2% of this breakdownUnited Kingdom: 405 citing papers, 8.3% of this breakdownFrance: 218 citing papers, 4.4% of this breakdownGermany: 211 citing papers, 4.3% of this breakdownJapan: 169 citing papers, 3.4% of this breakdownCanada: 167 citing papers, 3.4% of this breakdownSpain: 123 citing papers, 2.5% of this breakdownItaly: 122 citing papers, 2.5% of this breakdownNetherlands: 111 citing papers, 2.3% of this breakdownAustralia: 98 citing papers, 2% of this breakdownSweden: 72 citing papers, 1.5% of this breakdown
0%35.3%Other 20.9%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology46.4%
  • Medicine23.8%
  • Immunology and Microbiology21.8%
  • Agricultural and Biological Sciences5%
  • Computer Science1%
  • Environmental Science0.7%
  • Other1.3%

Topics

  • CRISPR and Genetic Engineering7.2%
  • HIV Research and Treatment5.3%
  • DNA Repair Mechanisms4.2%
  • Cancer Genomics and Diagnostics3.9%
  • Cytomegalovirus and herpesvirus research2.7%
  • Immune Cell Function and Interaction2.7%
  • Other74%

Coauthors

All papers

Open in search
  1. Evidence for APOBEC3B mutagenesis in multiple human cancers

    Authors: Michael B. Burns, Nuri A. Temiz, Reuben S. Harris - Nature Genetics 2013 cited by 790

  2. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA

    Authors: Erik N. Bergstrom, Jens Luebeck, Mia Petljak, Azhar Khandekar, Mark Barnes, Tongwu Zhang, Christopher D. Steele, Nischalan Pillay, Maria Teresa Landi, Vineet Bafna, Paul S. Mischel, Reuben S. Harris, Ludmil B. Alexandrov - Nature 2022 cited by 165

  3. APOBECs and virus restriction

    Authors: Reuben S. Harris, Jaquelin P. Dudley - Virology 2015 cited by 573

  4. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution

    Authors: Subramanian Venkatesan, Mihaela Angelova, Clare Puttick, Hao-Ran Zhai, Deborah R. Caswell, Wei-Ting Lu, Michelle Dietzen, Panagiotis Galanos, Konstantinos Evangelou, Roberto Bellelli, Emilia L. Lim, Thomas B.K. Watkins, Andrew Rowan, Vitor H. Teixeira, Yue Zhao, Haiquan Chen, Bryan Ngo, Lykourgos‐Panagiotis Zalmas, Maise Al Bakir, Sebastijan Hobor, Eva Grönroos, Adam Pennycuick, Ersilia Nigro, Brittany Campbell, William L. Brown, Ayse U. Akarca, Teresa Marafioti, Mary Wu, Michael Howell, Simon J. Boulton, Cosetta Bertoli, Tim R. Fenton, Robertus A.M. de Bruin, Apolinar Maya‐Mendoza, Eric Santoni‐Rugiu, Robert E. Hynds, Vassilis G. Gorgoulis, Mariam Jamal‐Hanjani, Nicholas McGranahan, Reuben S. Harris, Sam M. Janes, Jiřina Bártková, Samuel F. Bakhoum, Jiří Bártek, Nnennaya Kanu, Charles Swanton - Cancer Discovery 2021 cited by 143

  5. SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376

    Authors: Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, Chengjin Ye, Matteo Pavan, Davide Bassani, André Volland, Claudia Ascher, Alexander K. H. Weiss, David Bante, Reuben S. Harris, Stefano Moro, Bernhard Rupp, Luis Martínez‐Sobrido, Dorotheé von Laer - Science Translational Medicine 2022 cited by 138

  6. The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

    Authors: Deborah R. Caswell, Philippe Gui, Manasi K. Mayekar, Emily K. Law, Oriol Pich, Chris Bailey, Jesse Boumelha, D. Lucas Kerr, Collin M. Blakely, Tadashi Manabe, Carlos Martínez‐Ruiz, Björn Bakker, Juan De Dios Palomino Villcas, Natalie I. Vokes, Michelle Dietzen, Mihaela Angelova, Beatrice Gini, Whitney Tamaki, Paul Allegakoen, Wei Wu, Timothy J. Humpton, William Hill, Mona Tomaschko, Wei-Ting Lu, Franziska Haderk, Maise Al Bakir, A. Nagano, Francisco Gimeno-Valiente, Sophie de Carné Trécesson, Roberto Vendramin, Vittorio Barbè, Miriam Mugabo, Clare E. Weeden, Andrew Rowan, Caroline E. McCoach, Bruna Almeida, Mary Green, Carlos Gómez, Shigeki Nanjo, Dora Barbosa, Christopher Moore, Joanna Przewrocka, James R. Black, Eva Grönroos, Alejandro Suárez‐Bonnet, Simon L. Priestnall, Caroline Zverev, Scott Lighterness, James Cormack, Victor Olivas, Lauren Čech, Trisha Andrews, Brandon Rule, Yuwei Jiao, Xinzhu Zhang, Paul Ashford, Cameron Durfee, Subramanian Venkatesan, Nuri A. Temiz, Lisa Tan, Lindsay K. Larson, Prokopios P. Argyris, William L. Brown, Elizabeth A. Yu, Julia Rotow, Udayan Guha, Nitin Roper, Johnny Yu, Rachel I. Vogel, Nicholas J. Thomas, Antonio Marra, Pier Selenica, Helena A. Yu, Samuel F. Bakhoum, Su Kit Chew, Jorge S. Reis‐Filho, Mariam Jamal‐Hanjani, Karen H. Vousden, Nicholas McGranahan, Eliezer M. Van Allen, Nnennaya Kanu, Reuben S. Harris, Julian Downward, Trever G. Bivona, Charles Swanton - Nature Genetics 2023 cited by 87

  7. APOBEC3B is an enzymatic source of mutation in breast cancer

    Authors: Michael B. Burns, Lela Lackey, Michael A. Carpenter, Anurag S. Rathore, Allison M. Land, Brandon Leonard, Eric W. Refsland, Delshanee Kotandeniya, Natalia Tretyakova, Jason B. Nikas, Douglas Yee, Nuri A. Temiz, Duncan Donohue, Rebecca M. McDougle, William L. Brown, Emily K. Law, Reuben S. Harris - Nature 2013 cited by 888

  8. An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations

    Authors: Jesse Boumelha, Sophie de Carné Trécesson, Emily K. Law, Pablo Romero-Clavijo, Matthew A. Coelho, Kevin W. Ng, Edurne Mugarza, Christopher Moore, Sareena Rana, Deborah R. Caswell, Miguel Murillo, David C. Hancock, Prokopios P. Argyris, William L. Brown, Cameron Durfee, Lindsay K. Larson, Rachel I. Vogel, Alejandro Suárez‐Bonnet, Simon L. Priestnall, Philip East, Sarah J. Ross, George Kassiotis, Míriam Molina‐Arcas, Charles Swanton, Reuben S. Harris, Julian Downward - Cancer Research 2022 cited by 83

  9. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity

    Authors: Charles Swanton, Nicholas McGranahan, Gabriel J. Starrett, Reuben S. Harris - Cancer Discovery 2015 cited by 511

  10. Increasing Cas9-mediated homology-directed repair efficiency through covalent tethering of DNA repair template

    Authors: Eric J. Aird, Klaus N. Lovendahl, Amber St. Martin, Reuben S. Harris, Wendy R. Gordon - Communications Biology 2018 cited by 249

  11. Rapid resistance profiling of SARS-CoV-2 protease inhibitors

    Authors: Seyed Arad Moghadasi, Rayhan G. Biswas, Daniel A. Harki, Reuben S. Harris - npj Antimicrobials and Resistance 2023 cited by 51

  12. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo

    Authors: Emily K. Law, Rena Levin-Klein, Matthew C. Jarvis, Hyoung Kim, Prokopios P. Argyris, Michael A. Carpenter, Gabriel J. Starrett, Nuri A. Temiz, Lindsay K. Larson, Cameron Durfee, Michael B. Burns, Rachel I. Vogel, Spyridon Stavrou, Alexya N. Aguilera, Sandra Wagner, David A. Largaespada, Timothy K. Starr, Susan R. Ross, Reuben S. Harris - The Journal of Experimental Medicine 2020 cited by 154

  13. APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer

    Authors: Jennifer L. McCann, Agnese Cristini, Emily K. Law, Seo Yun Lee, Michael Tellier, Michael A. Carpenter, Chiara Beghè, Jae Jin Kim, Anthony Sanchez, Matthew C. Jarvis, Bojana Stefanovska, Nuri A. Temiz, Erik N. Bergstrom, Daniel J. Salamango, Margaret R. Brown, Shona Murphy, Ludmil B. Alexandrov, Kyle M. Miller, Natalia Gromak, Reuben S. Harris - Nature Genetics 2023 cited by 78

  14. APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis

    Authors: Sonja M. Wörmann, Amy Zhang, Fredrik I. Thege, Robert W. Cowan, Dhwani N. Rupani, Runsheng Wang, Sara L. Manning, Chris Gates, Wei-Sheng Wu, Rena Levin-Klein, Kimal Rajapakshe, Meifang Yu, Asha S. Multani, Ya’an Kang, Cullen M. Taniguchi, Katharina Schlacher, Melena D. Bellin, Matthew H. G. Katz, Michael P. Kim, Jason B. Fleming, Steven Gallinger, Ravikanth Maddipati, Reuben S. Harris, Faiyaz Notta, Susan R. Ross, Anirban Maitra, Andrew D. Rhim - Nature Cancer 2021 cited by 68

  15. RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators

    Authors: Reuben S. Harris, Svend K. Petersen‐Mahrt, Michael S. Neuberger - Molecular Cell 2002 cited by 613

  16. Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B

    Authors: Ke Shi, Michael Carpenter, Surajit Banerjee, Nadine M. Shaban, Kayo Kurahashi, Daniel J. Salamango, Jennifer L. McCann, Gabriel J. Starrett, Justin V. Duffy, Özlem Demir, Rommie E. Amaro, Daniel A. Harki, Reuben S. Harris, Hideki Aihara - Nature Structural & Molecular Biology 2016 cited by 269

  17. APOBEC3B drives PKR-mediated translation shutdown and protects stress granules in response to viral infection

    Authors: Lavanya Manjunath, Sunwoo Oh, Pedro Ortega, Alexis Bouin, Elodie Bournique, Ambrocio Sanchez, Pia M. Martensen, Ashley A. Auerbach, Jordan T. Becker, Marcus Seldin, Reuben S. Harris, Bert L. Semler, Rémi Buisson - Nature Communications 2023 cited by 45

  18. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer

    Authors: Emily K. Law, Anieta M. Sieuwerts, Kelly LaPara, Brandon Leonard, Gabriel J. Starrett, Amy M. Molan, Nuri A. Temiz, Rachel I. Vogel, Marion E. Meijer‐van Gelder, Fred C.G.J. Sweep, Paul N. Span, John A. Foekens, John W.M. Martens, Douglas Yee, Reuben S. Harris - Science Advances 2016 cited by 240

  19. Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases

    Authors: Cameron Durfee, Nuri A. Temiz, Rena Levin-Klein, Prokopios P. Argyris, Lene Alsøe, Sergio Carracedo, Alicia Alonso de la Vega, Joshua Proehl, Anna M. Holzhauer, Zachary J. Seeman, Xingyu Liu, Yu-Hsiu T. Lin, Rachel I. Vogel, Rocı́o Sotillo, Hilde Nilsen, Reuben S. Harris - Cell Reports Medicine 2023 cited by 56

  20. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer

    Authors: Michael A. Carpenter, Nuri A. Temiz, Mahmoud A. Ibrahim, Matthew C. Jarvis, Margaret R. Brown, Prokopios P. Argyris, William L. Brown, Gabriel J. Starrett, Douglas Yee, Reuben S. Harris - PLoS Genetics 2023 cited by 50

  21. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection

    Authors: Stefanie Jäger, Dong Young Kim, Judd F. Hultquist, Keisuke Shindo, Rebecca S. LaRue, Eunju Kwon, Ming Li, Brett D. Anderson, Linda Yen, David Stanley, Cathal Mahon, Joshua Kane, Kathy Franks-Skiba, Peter Cimermančič, Alma L. Burlingame, Andrej Šali, Charles S. Craik, Reuben S. Harris, John D. Gross, Nevan J. Krogan - Nature 2011 cited by 350

  22. The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers

    Authors: Brandon Leonard, Jennifer L. McCann, Gabriel J. Starrett, Leah Kosyakovsky, Elizabeth M. Luengas, Amy M. Molan, Michael B. Burns, Rebecca M. McDougle, Peter J. Parker, William L. Brown, Reuben S. Harris - Cancer Research 2015 cited by 139

  23. Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M pro /3CL pro in Living Cells

    Authors: Seyed Arad Moghadasi, Morgan A. Esler, Yuka Otsuka, Jordan T. Becker, Sofia N. Moraes, Constance B. Anderson, Srinivas Chamakuri, Christopher Belica, Chloe Wick, Daniel A. Harki, Damian W. Young, Louis Scampavia, Timothy Spicer, Ke Shi, Hideki Aihara, William L. Brown, Reuben S. Harris - mBio 2022 cited by 39

  24. Retroviral restriction by APOBEC proteins

    Authors: Reuben S. Harris, Mark T. Liddament - Nature reviews. Immunology 2004 cited by 657